References
- Rubin RL. Etiology and mechanisms of drug-induced lupus. Curr Opin Rheumatol. 1999;11:357–63.
- Spiera RF, Berman RS, Werner AJ, Spiera H. Ticlopidine-induced lupus: a report of 4 cases. Arch Intern Med. 2002; 162:2240–3.
- Pelizza L, De Luca P, La Pesa M, Minervino A. Drug-induced systemic lupus erythematosus after 7 years of treatment with carbamazepine. Acta Biomed. 2006;77:17–9.
- Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science. 1994;266:810–3.
- Vedove CD, Del Giglio M, Schena D, Girolomoni G. Drug-induced lupus erythematosus. Arch Dermatol Res. 2009;301:99–105.
- Braun-Moscovici Y, Schapira D, Balbir-Gurman A, Sevilia R, Nahir AM. Ticlopidine-induced lupus. J Clin Rheumatol. 2001;7:102–5.
- Matsuda M, Ooura N, Hattori T, Miki J, Tabata K. Drug-induced lupus possibly due to ticlopodine. Naika. 2001;88:181–3.
- Reich A, Bialynicki-Birula R, Szepietowski JC. Drug-induced subacute cutaneous lupus erythematosus resulting from ticlopi-dine. Int J. Dermatol. 2006;45:1112–4.
- Ohtake T, Kobayashi S, Okamoto K, et al. Ticlopidine-induced lupus with renal involvement. Nephrol Dial Transplant. 2006;21:1992–3.
- Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore). 2004;83:348–59.
- Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979;38:434–9.